ABCL
Price
$4.60
Change
-$0.06 (-1.29%)
Updated
Sep 29, 6:59 PM EST
39 days until earnings call
INO
Price
$0.39
Change
+$0.01 (+2.63%)
Updated
Sep 29, 6:59 PM EST
38 days until earnings call

Analysis and predictions ABCL vs INO

Header iconABCL vs INO Comparison
Open Charts ABCL vs INOBanner chart's image
AbCellera Biologics
Price$4.60
Change-$0.06 (-1.29%)
Volume$848.38K
CapitalizationN/A
Inovio Pharmaceuticals
Price$0.39
Change+$0.01 (+2.63%)
Volume$634.34K
CapitalizationN/A
View a ticker or compare two or three
ABCL vs INO Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
ABCL vs. INO commentary
Sep 30, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCL is a Hold and INO is a StrongSell.

COMPARISON
Comparison
Sep 30, 2023
Stock price -- (ABCL: $4.66 vs. INO: $0.38)
Brand notoriety: ABCL: Not notable vs. INO: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABCL: 60% vs. INO: 60%
Market capitalization -- ABCL: $1.35B vs. INO: $104.28M
ABCL [@Biotechnology] is valued at $1.35B. INO’s [@Biotechnology] market capitalization is $104.28M. The market cap for tickers in the [@Biotechnology] industry ranges from $410.54B to $0. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABCL’s FA Score shows that 0 FA rating(s) are green whileINO’s FA Score has 1 green FA rating(s).

  • ABCL’s FA Score: 0 green, 5 red.
  • INO’s FA Score: 1 green, 4 red.
According to our system of comparison, INO is a better buy in the long-term than ABCL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABCL’s TA Score shows that 3 TA indicator(s) are bullish while INO’s TA Score has 4 bullish TA indicator(s).

  • ABCL’s TA Score: 3 bullish, 4 bearish.
  • INO’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, INO is a better buy in the short-term than ABCL.

Price Growth

ABCL (@Biotechnology) experienced а -5.09% price change this week, while INO (@Biotechnology) price change was -1.78% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.08%. For the same industry, the average monthly price growth was +16.82%, and the average quarterly price growth was +35.61%.

Reported Earning Dates

ABCL is expected to report earnings on Nov 07, 2023.

INO is expected to report earnings on Nov 07, 2023.

Industries' Descriptions

@Biotechnology (+2.08% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for ABCL with price predictions.
OPEN
A.I.dvisor published
a Summary for INO with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
ABCL($1.35B) has a higher market cap than INO($104M). ABCL YTD gains are higher at: -53.998 vs. INO (-75.064). ABCL has higher annual earnings (EBITDA): -51.99M vs. INO (-162.17M). ABCL has more cash in the bank: 796M vs. INO (195M). INO has less debt than ABCL: INO (30.8M) vs ABCL (84M). ABCL has higher revenues than INO: ABCL (145M) vs INO (9.62M).
ABCLINOABCL / INO
Capitalization1.35B104M1,296%
EBITDA-51.99M-162.17M32%
Gain YTD-53.998-75.06472%
P/E Ratio11.98N/A-
Revenue145M9.62M1,507%
Total Cash796M195M408%
Total Debt84M30.8M273%
FUNDAMENTALS RATINGS
INO: Fundamental Ratings
INO
OUTLOOK RATING
1..100
8
VALUATION
overvalued / fair valued / undervalued
1..100
23
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
91
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABCLINO
RSI
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 1 day ago
83%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 1 day ago
75%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 1 day ago
84%
MACD
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 1 day ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 1 day ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 1 day ago
86%
Advances
ODDS (%)
N/A
Bullish Trend 3 days ago
75%
Declines
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 9 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 1 day ago
73%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 1 day ago
86%
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MSOCX19.190.09
+0.47%
Morgan Stanley Inst International Opp C
PVEJX15.32N/A
N/A
Principal MidCap Value I J
EKSDX5.24N/A
N/A
Allspring Diversified Income Bldr Adm
EMECX8.88N/A
N/A
Ashmore Emerging Markets Equity C
PVCCX10.07-0.05
-0.49%
Pioneer Intrinsic Value C

INO and

Correlation & Price change

A.I.dvisor indicates that over the last year, INO has been loosely correlated with IMGN. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if INO jumps, then IMGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INO
1D Price
Change %
INO100%
+2.45%
IMGN - INO
61%
Loosely correlated
-0.84%
MDGL - INO
56%
Loosely correlated
-3.84%
NTLA - INO
54%
Loosely correlated
-0.50%
BEAM - INO
53%
Loosely correlated
+0.12%
AXON - INO
53%
Loosely correlated
+1.48%
More